Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,744,079,292
+$45,549,820 QoQ
Shares Held
6,867,265
-1.2% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#40
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $11,745,589,806 across 15 Drug Manufacturers - General names. JNJ ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,261,385 | $5,111,233,436 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,867,265 | $1,744,079,292 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,131,942 | $1,687,454,547 | |
| 4 | ABBV |
AbbVie Inc.
|
4,092,335 | $1,029,795,179 | |
| 5 | AZN |
Astrazeneca PLC
|
4,345,439 | $823,982,143 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,613,383 | $582,854,808 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,757,720 | $274,139,826 | |
| 8 | AMGN |
Amgen Inc
|
587,270 | $212,662,212 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,744,079,292 | 6,867,265 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,698,529,472 | 6,948,656 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,592,563,443 | 7,695,402 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,470,864,917 | 7,932,612 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,206,912,424 | 7,901,227 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,291,271,700 | 7,786,250 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $914,465,233 | 6,323,228 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,012,674,531 | 6,248,763 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $689,074,681 | 4,714,523 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $822,364,161 | 5,198,585 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $868,343,831 | 5,540,027 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $932,761,985 | 5,988,841 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,189,035,927 | 7,183,639 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,264,054,605 | 8,155,191 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,378,520,425 | 7,803,682 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $1,156,848,869 | 7,081,592 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $1,317,143,193 | 7,420,107 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,230,771,076 | 6,944,485 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,185,317,000 | 6,928,842 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,070,655,690 | 6,629,447 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,078,411,268 | 6,546,141 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $1,090,121,552 | 6,632,927 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $1,334,055,649 | 8,476,653 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,550,186,499 | 10,412,322 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,457,224,794 | 10,362,119 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,418,551,489 | 10,817,902 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||